Pulmonx’s latest price target update keeps fair value steady at $5.75 per share while slightly lowering the discount rate to reflect a modestly reduced risk profile. With revenue growth expectations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback